MedPath

An open-label, multi-institutional, randomized study to evaluate the additive effect of leukotriene receptor antagonist on cough score in patients with cough-variant asthma treated with inhaled corticosteroid

Not Applicable
Conditions
cough-variant asthma
Registration Number
JPRN-UMIN000033398
Lead Sponsor
Kobe University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

We excluded patients if they were diagnosed with bronchial asthma, atopic cough, sinobronchial syndrome, tuberculosis and lung cancer.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cough score and peak expiratory flow (PEF)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath